Mirum Pharmaceuticals (MIRM) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Mirum Pharmaceuticals, as the data feed reports them.

Analysts' mean target, 13 analysts
$157.71
71.5% above the price

The 13 analysts reported by the data feed have a mean price target for Mirum Pharmaceuticals of $157.71, 71.5% above the $91.95 price (range $118.00–$202.28). 12.84% of the float was sold short as of Oct 30, 2026. Institutions hold 111.2% of the shares and insiders 1.3%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$157.71+71.5% vs price
Analysts
13
Short interest
12.84%of float, Oct 30, 2026
Short ratio
8.65 days
Institutions
111.2%
Insiders
1.31%
Beta
0.74

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

13 analysts covering Mirum Pharmaceuticals, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $91.95.

Analysts' price targets for Mirum Pharmaceuticals
Mean price target$157.7171.5% above the price (+71.5%)
Median price target$155.0068.6% above the price (+68.6%)
Highest target$202.28120.0% above the price (+120.0%)
Lowest target$118.0028.3% above the price (+28.3%)
Analysts with a target13

Ratings this month · 12 analysts

Strong buy 4(33%)Buy 8(67%)
Analysts' ratings of Mirum Pharmaceuticals this month, by rating
RatingAnalystsShare
Strong buy433%
Buy867%
Hold00%
Sell00%
Strong sell00%

The feed averages these to 1.33 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Mirum Pharmaceuticals

Ownership of Mirum Pharmaceuticals
Held by institutions111.2%438 institutions; percent of shares outstanding
Held by institutions, of the float112.7%
Held by insiders1.31%percent of shares outstanding
Shares outstanding65.28M
Float56.74Mshares available to trade
Insiders' net purchases, six months+44.2K16 purchases (243.93K shares), 16 sales (199.73K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Mirum Pharmaceuticals
Shares short6.52Mas of Oct 30, 2026
Percent of float12.84%shares short ÷ float
Percent of shares outstanding9.99%shares short ÷ shares outstanding
Short ratio (days to cover)8.65shares short ÷ average daily volume

Mirum Pharmaceuticals short interest from FINRA, with its history

Trading figures

Trading figures for Mirum Pharmaceuticals
Beta0.74movement against the market; 1 moves with it
52-week high$130.00
52-week low$63.23
Average volume, 3 months683.81Kshares a day
Average volume, 10 days647.82Kshares a day

Questions and answers

What is the analysts' price target for Mirum Pharmaceuticals (MIRM)?

As reported by the data feed, the mean price target of the 13 analysts covering Mirum Pharmaceuticals is $157.71, 71.5% above the latest price of $91.95. The highest target is $202.28 and the lowest $118.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Mirum Pharmaceuticals stock?

Of the 12 ratings the data feed reports for the current month, 4 are strong buy, 8 buy, 0 hold, 0 sell and 0 strong sell.

How many Mirum Pharmaceuticals shares are sold short?

As reported by the data feed, 6.52M shares were sold short, 12.84% of the float as of Oct 30, 2026. At the average daily volume that is 8.65 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Mirum Pharmaceuticals stock?

As reported by the data feed, institutions hold 111.2% of the shares (438 institutions) and insiders 1.3%. There are 65.28M shares outstanding, of which 56.74M are in the float.

How much does Mirum Pharmaceuticals stock move with the market?

Its beta, as reported by the data feed, is 0.74: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $63.23 and $130.00.

Cite this page

Funkfolio, “Mirum Pharmaceuticals (MIRM) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/MIRM/statistics

Underlying data: Yahoo Finance.